Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus : a double - blind comparison with parenteral immunotherapy . 
<br>
<br> To verify the efficacy and the tolerability of local immunotherapy ( LI ) by inhalation of a powder extract of house dust mite ( HDM ) , in comparison with parenteral immunotherapy ( PI ) by injection , 10 patients with asthma due to HDM were studied in a blind fashion . 5 patients ( Group A ) underwent LI and subcutaneous injections of placebo , 5 patients ( Group B ) underwent PI and inhalation of lactose for 6 months . In both groups each inhalation was preceded by premedication with disodium cromoglycate ( DSCG ) ( 40 mg ) . In Group A a <font color="blue">significant_1</font> <font color="blue">decrease_1</font> <font color="blue">in_1</font> <font color="blue">symptoms_3</font> <font color="blue">score_3</font> <font color="blue">and_1</font> <font color="blue">in_1</font> <font color="blue">peak_4</font> <font color="blue">expiratory_4</font> <font color="blue">flow_4</font> <font color="blue">(_3</font> <font color="blue">PEF)-derived_3</font> <font color="blue">parameters_3</font> was observed already after 3 months of treatment , and 2 patients lost the late component of the bronchial response to the challenge with HDM . <font color="blue">No_1</font> <font color="blue">significant_1</font> <font color="blue">variation_1</font> was found in <font color="blue">bronchial_5</font> <font color="blue">responsiveness_5</font> <font color="blue">to_2</font> <font color="blue">methacholine_2</font> <font color="blue">and_2</font> <font color="blue">ultrasonically_3</font> <font color="blue">nebulized_3</font> <font color="blue">distilled_3</font> <font color="blue">water_3</font> <font color="blue">(_3</font> <font color="blue">UNDW_3</font> <font color="blue">)_3</font> <font color="blue">and_2</font> <font color="blue">in_2</font> <font color="blue">immunologic_4</font> <font color="blue">humoral_4</font> <font color="blue">and_4</font> <font color="blue">cellular_4</font> <font color="blue">parameters_4</font> <font color="blue">in_2</font> <font color="blue">peripheral_2</font> <font color="blue">blood_2</font> <font color="blue">after_1</font> <font color="blue">treatment_1</font> in either group . <font color="blue">No_1</font> <font color="blue">local_3</font> <font color="blue">important_3</font> <font color="blue">adverse_4</font> <font color="blue">reactions_4</font> were observed in Group A and no <font color="blue">systemic_2</font> <font color="blue">side_2</font> <font color="blue">effects_2</font> were observed in either group . We conclude that LI is as effective as PI , but more rapid in its action , in the treatment of asthma due to HDM . Moreover , LI is locally well tolerated , providing DSCG is inhaled before each therapeutic inhalation , and does not induce <font color="blue">systemic_1</font> <font color="blue">side_1</font> <font color="blue">effects_1</font> <font color="blue">._1</font>